AnalystsMartin Fan
Martin Fan's Stock Forecasts

Analyst Ranking
Top 9%
#497 out of 5544 analysts
Average Return
+24.64%
Win Rate
35%15 out of 43
Risk vs Reward
Poor
Good

Martin Fan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Oruka Therapeutics IncORKA
+575.48%$9.46$63.90
2025-05-15 -
2026-05-14
Buy
Aclaris Therapeutics IncACRS
+224.82%$1.41$4.58
2025-05-28 -
2026-05-27
Buy
Anaptysbio IncANAB
+202.90%$21.70$65.73
2025-05-01 -
2026-04-30
Buy
Anaptysbio IncANAB
+168.88%$20.37$54.77
2025-08-07 -
2026-08-06
Buy
Zenas Biopharma IncZBIO
+161.74%$8.52$22.30
2025-03-20 -
2026-03-20
Buy

Martin Fan Analyst Color

Get additional color on Martin Fan's coverage of popular stocks

Martin Fan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Zenas Biopharma IncZBIO
5Buy$45.00+81.16%Reiterates
19 days ago
Oruka Therapeutics IncORKA
6Buy$165.00+129.39%Reiterates
25 days ago
Eupraxia Pharmaceuticals IncEPRX
1Buy$17.00+156.80%Initiates Coverage On
25 days ago
Nektar TherapeuticsNKTR
4Hold$50.00+39.74%Maintains
a month ago
Immunic IncIMUX
2Buy$45.00+545.62%Reiterates
a month ago
Cartesian Therapeutics IncRNAC
6Buy$38.00+506.06%Reiterates
2 months ago
Fate Therapeutics IncFATE
1Buy$7.00+291.06%Reiterates
2 months ago
First Tracks Biotherapeutics IncTRAX
2Buy$70.00+103.13%Maintains
2 months ago
Vor Biopharma IncVOR
4Hold$27.00+49.75%Maintains
2 months ago
Zura Bio LtdZURA
3Buy$22.00+467.01%Maintains
2 months ago
Imagenebio IncIMA
2Sell$2.00-50.50%Reiterates
5 months ago
Artiva Biotherapeutics IncARTV
3Buy$40.00+583.76%Maintains
5 months ago
Aclaris Therapeutics IncACRS
3Buy$10.00+204.88%Maintains
6 months ago
Sana Biotechnology IncSANA
3Buy$7.00+208.37%Maintains
6 months ago
Anaptysbio IncANAB
6Buy$75.00+60.91%Maintains
7 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.